Requisites for successful theranostics with radionuclide-based reporter gene imaging. - Wikidata - awgldk - TriplyDB

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

http://www.wikidata.org/entity/Q38177892

about

Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells Theranostic studies of human sodium iodide symporter imaging and therapy using 188Re: a human glioma study in mice.Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging.Detecting Tumor Metastases: The Road to Therapy Starts Here.Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies.Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model.Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.Bovine serum albumin coated nanoparticles for in vitro activated fluorescence.Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I.An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles.New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model

P2860

Q28076866-178B52D4-6E4C-453A-892A-4A4C9900F785 Q33856421-E7FD0284-DF33-4CD7-A22E-29C7CF7DA488 Q37637322-C0C7AEDD-DB28-4446-90DD-A1E038BFF861 Q38950545-6C6EC6F4-2277-42F1-B6C9-D4AC4D28B8D5 Q39354309-6F695456-9188-4A3E-B7E1-6551A89CB1F1 Q41074467-53913D92-09A6-4CC2-A991-FD93E90854D6 Q41573147-3A3F844D-7B4C-4759-AAF9-7435ED31421B Q41684107-D9EEE578-8216-4E3C-B216-B4767ABC8741 Q51092216-5FD83BE7-2BA8-45DC-B8AE-8C1D02C4FBA5 Q51749228-A3E85162-BC48-4199-98B8-B739E9050721 Q55004583-897D397E-232E-471C-9085-E5398735D685 Q58756331-FAF82709-8BB8-45C2-84C3-715E8A7BDAD7

P2860

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

http://www.wikidata.org/entity/Q38177892

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

@en

type

label

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

@en

prefLabel

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

@en

P1433

Q38177892-6EDA77CA-F3DB-495A-B8BA-224BEE6F88DE

P1476

Q38177892-8DF454F4-965F-4369-9906-4BDCAFA449ED

P2093

Q38177892-A61AB4E1-32D6-4790-AE68-09FFF46F6E40

P2860

Q38177892-03FFD3C8-21D8-4F88-888E-7ED2391C9393

Q38177892-0EA8FD5D-7951-49F4-9304-58E160E370EF

Q38177892-1FF97D44-6DE0-4501-9B93-FA5D272BE4FA

Q38177892-28AB0D4A-4E51-4B92-B2C7-B1F69843D0B6

Q38177892-2A8752AB-D66D-4C27-B84E-E16B09A8D3CD

Q38177892-346C5675-8A32-42A3-91B0-C046BA3C60F1

Q38177892-37177BF0-2662-42E9-91CA-ADBB3CB4CEEE

Q38177892-41867480-0771-415A-9020-3D672ECAFDF4

Q38177892-4555C6BD-5ECF-4706-96E6-9358F9D67D32

Q38177892-5590EB84-ED20-4B2D-9BB7-37C540A4CD03

P304

Q38177892-5817FEC4-DFEC-42DD-A4AC-33403CB5E473

P31

Q38177892-F5E172F5-0734-42F6-AF43-3A90C0003FA6

P356

Q38177892-4ABFEEA2-D33B-4364-9C38-FF9243C9D713

P433

Q38177892-6E70D82F-3D87-46D9-B320-3F915A35436A

P478

Q38177892-EEFA6FAE-06CB-4B77-ADC0-6A0E0697CF8A

P577

Q38177892-CA456C3A-891B-407A-AA7E-44D7BCBFEA90

P698

Q38177892-0CF35BD3-B14E-4334-8537-8D5AB39654A1

P356

1061186X.2013.878940

P1433

Journal of Drug Targeting

P1476

Requisites for successful theranostics with radionuclide-based reporter gene imaging.

@en

P2093

Byeong-Cheol Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

Imaging in the era of molecular oncology.

In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Therapeutic nanoparticles for drug delivery in cancer

In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.

Enhancer function: new insights into the regulation of tissue-specific gene expression.

Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector.

Suicide gene therapy in cancer: where do we stand now?

Targeting tumors with non-viral gene delivery systems.

P304

295-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2013.878940

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24417717

http://www.w3.org/2001/XMLSchema#string